Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
No Weighted Avg Shares (Diluted) data reported for this period type.
Weighted Avg Shares (Diluted) vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 311.38M | +6.5% | +6.9% | |
| LTM Jun 2026 | 214.47M | +18.7% | +20.2% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | 142.11M | +51.7% | +47.9% |
| LTM Mar 2026 | 99.92M | -2.8% | +10.9% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — |
| Peer median (excluding AVLN) | 178.29M | +12.6% | +15.5% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.